Baxter (BAX) Updates H215, FY16 Outlook

Baxter (NYSE: BAX) updated its outlook on Monday:

-- Sees FY16 adjusted operating margin about 10 percent
-- Sees FY16 adjusted EBITDA margin about 16 percent
-- Sees FY16 operating cash flow about $1.3 billion
-- Sees FY16 sales growth about 2 - 3 percent
-- Sees H215 sales down about 9 percent on a reported basis
-- Sees H215 adjusted operating margin at about 9 percent
-- Sees H215 adjusted EBITDA margin at about 15 percent

Data comes from a slide presentation Monday.

You May Also Be Interested In

• Biogen (BIIB) tops earnings expectations but revenue falls short
• Amphenol (APH) Tops Q1 EPS by 7c, offers guidance
• NVIDIA (NVDA) has agreed to acquire Run:ai